Shi, Yafei, Yanhui Li, Wei Chen, Mingyu Zhang, Di Qian, Taifeng Li, Yuanyuan Dai, and Guohui Li. 2024. “Cost-Effectiveness Analysis of Sintilimab Vs. Docetaxel As the Second-Line Therapy of Squamous Non-Small Cell Lung Cancer in China”. Health Decision 2 (S1). https://doi.org/10.54844/hd.2024.0007.